Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of Withaferin A and Its Derivatives in the Management of Alzheimer’s Disease: Recent Trends and Future Perspectives
Rajib Das, Abdur Rauf, Saima Akhter, et al.
Molecules (2021) Vol. 26, Iss. 12, pp. 3696-3696
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Ashwagandha (Withania somnifera)—Current Research on the Health-Promoting Activities: A Narrative Review
Paulina Mikulska, Marta Malinowska, Miłosz Ignacyk, et al.
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1057-1057
Open Access | Times Cited: 101
Understanding of Alzheimer's Disease Pathophysiology for Therapeutic Implications of Natural Products as Neuroprotective Agents
Sneh Prabha, Arunabh Choudhury, Asimul Islam, et al.
Ageing Research Reviews (2025), pp. 102680-102680
Closed Access | Times Cited: 2
l-carnitine: Nutrition, pathology, and health benefits
Abdulaziz Hassan Alhasaniah
Saudi Journal of Biological Sciences (2022) Vol. 30, Iss. 2, pp. 103555-103555
Open Access | Times Cited: 51
An updated review on phytochemistry and molecular targets of Withania somnifera (L.) Dunal (Ashwagandha)
Arsalan Bashir, Masarat Nabi, Nahida Tabassum, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 32
Deep Belief Networks (DBN) with IoT-Based Alzheimer’s Disease Detection and Classification
Nayef Alqahtani, Shadab Alam, Ibrahim Aqeel, et al.
Applied Sciences (2023) Vol. 13, Iss. 13, pp. 7833-7833
Open Access | Times Cited: 25
Unveiling the impact of aging on BBB and Alzheimer's disease: Factors and therapeutic implications
Niraj Kumar Jha, Niraj Kumar Jha, Mohana Vamsi Nuli, et al.
Ageing Research Reviews (2024) Vol. 98, pp. 102224-102224
Closed Access | Times Cited: 14
Acute and Repeated Ashwagandha Supplementation Improves Markers of Cognitive Function and Mood
Megan Leonard, Broderick Dickerson, Landry Estes, et al.
Nutrients (2024) Vol. 16, Iss. 12, pp. 1813-1813
Open Access | Times Cited: 10
Flavonoids and Alzheimer’s disease: reviewing the evidence for neuroprotective potential
Md. Al Amin, Zerrouki Dehbia, Mohamed H. Nafady, et al.
Molecular and Cellular Biochemistry (2024)
Closed Access | Times Cited: 6
Safety, toxicity and pharmacokinetic assessment of oral Withaferin-A in mice
Saurabh Kumar Gupta, Shraddha Jadhav, Dievya Gohil, et al.
Toxicology Reports (2022) Vol. 9, pp. 1204-1212
Open Access | Times Cited: 23
Withania somnifera (L.) Dunal (Ashwagandha); current understanding and future prospect as a potential drug candidate
Javeed Ahmad Bhat, Tahira Akther, Rauf Ahmad Najar, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 23
Clinical pharmacokinetic evaluation of Withania somnifera (L.) Dunal root extract in healthy human volunteers: A non-randomized, single dose study utilizing UHPLC-MS/MS analysis
V. G. Vaidya, Ninad Naik, Gayatri Ganu, et al.
Journal of Ethnopharmacology (2023) Vol. 322, pp. 117603-117603
Closed Access | Times Cited: 15
Role of lipid droplets in neurodegenerative diseases: From pathogenesis to therapeutics
Yubing Kang, Yee Jie Yeap, Jing Yang, et al.
Neuroscience & Biobehavioral Reviews (2024) Vol. 165, pp. 105867-105867
Open Access | Times Cited: 5
Promising Natural Remedies for Alzheimer’s Disease Therapy
Amin Mahmood Thawabteh, Aseel Wasel Ghanem, Sara AbuMadi, et al.
Molecules (2025) Vol. 30, Iss. 4, pp. 922-922
Open Access
An open-label, single dose, safety and pharmacokinetic study of Withania somnifera root extract in healthy volunteers
Eshita Sharma, Gayatri Ganu, Ketan Kshirsagar, et al.
Drug Metabolism and Personalized Therapy (2025)
Open Access
Decoding the Role of Astrocytes in the Entorhinal Cortex in Alzheimer’s Disease Using High-Dimensional Single-Nucleus RNA Sequencing Data and Next-Generation Knowledge Discovery Methodologies: Focus on Drugs and Natural Product Remedies for Dementia
Peter Natesan Pushparaj, Kalamegam Gauthaman, Khalid Sait, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 21
Natural plant products as effective alternatives to synthetic chemicals for postharvest fruit storage management
Nahidun Nesa Chowdhury, Mohammad Nazmul Islam, Rifat Jafrin, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 63, Iss. 30, pp. 10332-10350
Closed Access | Times Cited: 19
Covalent binding of withanolides to cysteines of protein targets
Christian Bailly
Biochemical Pharmacology (2024) Vol. 226, pp. 116405-116405
Open Access | Times Cited: 3
Advances in Immunosuppressive Agents Based on Signal Pathway
Zhiqing Xu, Ming Chu
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 15
Effects of Withania somnifera on Cortisol Levels in Stressed Human Subjects: A Systematic Review
M. Porta, Jeanette A.M. Maier, Roberta Cazzola
Nutrients (2023) Vol. 15, Iss. 24, pp. 5015-5015
Open Access | Times Cited: 8
Clinical safety and tolerability evaluation of Withania somnifera (L.) Dunal (Ashwagandha) root extract in healthy human volunteers
V. G. Vaidya, Amol Gothwad, Gayatri Ganu, et al.
Journal of Ayurveda and Integrative Medicine (2023) Vol. 15, Iss. 1, pp. 100859-100859
Open Access | Times Cited: 8
A Comprehensive Review on L-carnitine: A Promising Nutraceutical
AA Gunjal, AV Kulkarni, PK Bairagi, et al.
International Journal of Pharmaceutical Sciences and Drug Research (2024), pp. 517-532
Open Access | Times Cited: 2
Natural Products as Bioactive Agents in the Prevention of Dementia
Mahmood Rasool, Hamid Ullah, Abrar Hussain, et al.
CNS & Neurological Disorders - Drug Targets (2022) Vol. 22, Iss. 4, pp. 466-476
Closed Access | Times Cited: 10
Proteomic analysis and experimental validation reveal the blood–brain barrier protective of Huanshaodan in the treatment of SAMP8 mouse model of Alzheimer’s disease
Yunfang Su, Ningning Liu, Pan Wang, et al.
Chinese Medicine (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
Withaferin-A alleviates acute graft versus host disease without compromising graft versus leukemia effect
Saurabh Gupta, Dievya Gohil, Deepshikha Dutta, et al.
International Immunopharmacology (2023) Vol. 121, pp. 110437-110437
Closed Access | Times Cited: 4
Ashwagandha-Induced Programmed Cell Death in the Treatment of Breast Cancer
Renata Kołodziejska, Agnieszka Tafelska‐Kaczmarek, Mateusz Pawluk, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 7, pp. 7668-7685
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top